Rocket One Inc. Research and Development Expense
Rocket One Inc. (RKTO) reported Research and Development Expense of $1.96 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-14
- Rocket One Inc. research and development expense for the quarter ending 2026-06-30 was $1.96M, a 88.07% increase year-over-year.
- Rocket One Inc. research and development expense for the quarter ending 2026-03-31 was $1.52M, a 22.44% decline year-over-year.
- Rocket One Inc. research and development expense for the quarter ending 2025-12-31 was $1.31M, a 26.53% increase year-over-year.
- Rocket One Inc. research and development expense for the quarter ending 2025-09-30 was $1.63M, a 64.26% increase year-over-year.
- Rocket One Inc. research and development expense for fiscal 2025 was $5.95M, a 83.02% increase from fiscal 2024.
- Rocket One Inc. research and development expense for fiscal 2024 was $3.25M, a 13.14% decline from fiscal 2023.
- Rocket One Inc. research and development expense for fiscal 2023 was $3.74M, a 24.14% decline from fiscal 2022.
- Rocket One Inc. research and development expense for fiscal 2022 was $4.93M, a 32.95% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 8 month | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.96M 10-Q · filed 2026-08-14 | $3.47M 10-Q · filed 2026-08-14 | $4.79M derived: sum of 3 quarters · filed 2026-08-14 | $6.42M derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2026-03-31 | $1.52M 10-Q · filed 2026-05-15 | $2.83M derived: sum of 2 quarters · filed 2026-05-15 | $4.47M derived: sum of 3 quarters · filed 2026-05-15 | $5.51M derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2025-12-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $2.95M derived: sum of 2 quarters · filed 2026-03-27 | $3.99M derived: sum of 3 quarters · filed 2026-08-14 | $5.95M 10-K · filed 2026-03-27 | |||||
| 2025-09-30 | $1.63M 10-Q · filed 2025-11-12 | $2.67M derived: sum of 2 quarters · filed 2026-08-14 | $4.63M 10-Q · filed 2025-11-12 | $5.67M derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2025-06-30 | $1.04M 10-Q · filed 2026-08-14 | $3.00M 10-Q · filed 2026-08-14 | $4.04M derived: sum of 3 quarters · filed 2026-08-14 | $5.03M derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2025-03-31 | $1.96M 10-Q · filed 2026-05-15 | $3.00M derived: sum of 2 quarters · filed 2026-05-15 | $3.99M derived: sum of 3 quarters · filed 2026-05-15 | $4.64M derived: sum of 4 quarters · filed 2026-05-15 | |||||
| 2024-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $2.03M derived: sum of 2 quarters · filed 2026-03-27 | $2.68M derived: sum of 3 quarters · filed 2026-03-27 | $3.25M 10-K · filed 2026-03-27 | |||||
| 2024-09-30 | $994.47K 10-Q · filed 2025-11-12 | $897.51K 10-Q · filed 2024-11-12 | $1.64M derived: sum of 2 quarters · filed 2025-11-12 | $2.21M 10-Q · filed 2025-11-12 | $1.93M 10-Q · filed 2024-11-12 | $3.01M derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | $644.02K 10-Q · filed 2025-08-12 | $566.34K 10-Q · filed 2024-08-09 | $1.22M 10-Q · filed 2025-08-12 | $1.03M 10-Q · filed 2024-08-09 | $2.01M derived: sum of 3 quarters · filed 2025-08-12 | $3.35M derived: sum of 4 quarters · filed 2025-08-12 | |||
| 2024-03-31 | $571.64K 10-Q · filed 2025-05-12 | $465.90K 10-Q · filed 2024-05-14 | $1.37M derived: sum of 2 quarters · filed 2025-05-12 | $2.71M derived: sum of 3 quarters · filed 2025-05-12 | $3.37M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | $796.76K derived: 10-K 12 month − 10-K 9 month · filed 2025-03-28 | $2.13M derived: sum of 2 quarters · filed 2025-03-28 | $2.80M derived: sum of 3 quarters · filed 2025-03-28 | $3.74M 10-K · filed 2025-03-28 | $3.48M 10-K · filed 2024-03-28 | ||||
| 2023-09-30 | $1.34M 10-K · filed 2025-03-28 | $1.25M 10-Q · filed 2023-11-13 | $2.00M derived: sum of 2 quarters · filed 2025-03-28 | $2.94M 10-K · filed 2025-03-28 | $2.78M 10-Q · filed 2023-11-13 | $4.50M derived: sum of 4 quarters · filed 2025-03-28 | |||
| 2023-06-30 | $664.00K 10-K · filed 2025-03-28 | $640.96K 10-Q · filed 2023-08-11 | $1.61M 10-K · filed 2025-03-28 | $1.53M 10-Q · filed 2023-08-11 | $3.17M derived: sum of 3 quarters · filed 2025-03-28 | $4.62M derived: sum of 4 quarters · filed 2025-03-28 | |||
| 2023-03-31 | $942.89K 10-K · filed 2025-03-28 | $890.85K 10-Q · filed 2023-05-15 | $2.50M derived: sum of 2 quarters · filed 2025-03-28 | $3.95M derived: sum of 3 quarters · filed 2025-03-28 | $4.93M derived: sum of 4 quarters · filed 2025-03-28 | ||||
| 2022-12-31 | $1.56M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $3.01M derived: sum of 2 quarters · filed 2024-03-28 | $3.98M derived: sum of 3 quarters · filed 2024-03-28 | $4.93M 10-K · filed 2024-03-28 | $4.84M 10-K · filed 2023-03-31 | ||||
| 2022-09-30 | $1.45M 10-Q · filed 2023-11-13 | $2.42M derived: sum of 2 quarters · filed 2023-11-13 | $3.37M 10-Q · filed 2023-11-13 | $5.32M derived: sum of 4 quarters · filed 2023-11-13 | |||||
| 2022-06-30 | $971.18K 10-Q · filed 2023-08-11 | $1.92M 10-Q · filed 2023-08-11 | $3.87M derived: sum of 3 quarters · filed 2023-08-11 | $5.99M derived: sum of 4 quarters · filed 2023-08-11 | |||||
| 2022-03-31 | $948.38K 10-Q · filed 2023-05-15 | $2.89M derived: sum of 2 quarters · filed 2023-05-15 | $5.02M derived: sum of 3 quarters · filed 2023-05-15 | $6.77M derived: sum of 4 quarters · filed 2023-05-15 | |||||
| 2021-12-31 | $1.95M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $4.07M derived: sum of 2 quarters · filed 2023-03-31 | $5.82M derived: sum of 3 quarters · filed 2023-03-31 | $7.35M 10-K · filed 2023-03-31 | |||||
| 2021-09-30 | $2.12M 10-Q · filed 2022-11-10 | $3.88M derived: sum of 2 quarters · filed 2022-11-10 | $5.41M 10-Q · filed 2022-11-10 | $5.60M derived: sum of 4 quarters · filed 2022-11-10 | |||||
| 2021-06-30 | $1.75M 10-Q · filed 2022-08-12 | $3.28M 10-Q · filed 2022-08-12 | $3.47M derived: sum of 3 quarters · filed 2022-08-12 | $3.99M derived: sum of 4 quarters · filed 2022-08-12 | |||||
| 2021-03-31 | $1.53M 10-Q · filed 2022-05-12 | $1.72M derived: sum of 2 quarters · filed 2022-05-12 | $2.24M derived: sum of 3 quarters · filed 2022-05-12 | $3.17M derived: sum of 4 quarters · filed 2022-05-12 | |||||
| 2020-12-31 | $188.60K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $706.44K derived: sum of 2 quarters · filed 2022-03-30 | $1.63M derived: sum of 3 quarters · filed 2022-03-30 | $2.28M 10-K · filed 2022-03-30 | |||||
| 2020-09-30 | $517.84K 10-Q · filed 2021-11-10 | $1.45M derived: sum of 2 quarters · filed 2021-11-10 | $2.09M 10-Q · filed 2021-11-10 | $3.10M derived: sum of 4 quarters · filed 2021-11-10 | |||||
| 2020-06-30 | $927.70K 10-Q · filed 2021-08-11 | $1.57M 10-Q · filed 2021-08-11 | $2.59M derived: sum of 3 quarters · filed 2021-08-11 | $3.08M derived: sum of 4 quarters · filed 2021-08-11 | |||||
| 2020-03-31 | $647.23K 10-Q · filed 2021-05-13 | $1.66M derived: sum of 2 quarters · filed 2021-05-13 | $2.15M derived: sum of 3 quarters · filed 2021-05-13 | $2.54M derived: sum of 4 quarters · filed 2021-05-13 | |||||
| 2019-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $1.50M derived: sum of 2 quarters · filed 2021-03-16 | $1.89M derived: sum of 3 quarters · filed 2021-03-16 | $2.03M 10-K · filed 2021-03-16 | |||||
| 2019-09-30 | $490.27K 10-Q · filed 2020-11-10 | $879.20K derived: sum of 2 quarters · filed 2020-11-10 | $1.01M 10-Q · filed 2020-11-10 | $1.24M derived: sum of 4 quarters · filed 2020-11-10 | |||||
| 2019-06-30 | $388.93K 10-Q · filed 2020-08-13 | $523.68K 10-Q · filed 2020-08-13 | $751.57K derived: sum of 3 quarters · filed 2020-08-13 | $1.05M derived: sum of 4 quarters · filed 2020-08-13 | |||||
| 2019-03-31 | $134.75K 10-Q · filed 2020-05-13 | $362.63K derived: sum of 2 quarters · filed 2020-05-13 | $662.12K derived: sum of 3 quarters · filed 2020-05-13 | $878.78K derived: sum of 4 quarters · filed 2020-05-13 | |||||
| 2018-12-31 | $227.88K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $527.37K derived: sum of 2 quarters · filed 2020-03-02 | $744.03K derived: sum of 3 quarters · filed 2020-03-02 | $785.27K 10-K · filed 2020-03-02 | |||||
| 2018-09-30 | $299.49K 10-Q · filed 2019-11-12 | $516.15K derived: sum of 2 quarters · filed 2019-11-12 | $557.39K 10-Q · filed 2019-11-12 | ||||||
| 2018-06-30 | $216.67K 10-Q · filed 2019-08-14 | $257.91K 10-Q · filed 2019-08-14 | |||||||
| 2018-03-31 | $41.24K 10-Q · filed 2019-05-15 | ||||||||
| 2017-12-31 | $67.28K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |